Elucidating molecular mechanisms of chemotherapy resistance and DNA repair in ovarian cancer.
Using bioinformatic tools to understand genomic factors that drive tumor progression.
Manipulating gene expressions to enhance the efficacy of chemotherapeutic agents and contribute to cancer treatment modalities.
Molecular changes in the components of pyroptotic cell death pathways.
09.22.2022
Our lab received two more grants (TUBITAK 1002)…
In one of them, we will scrutinize the relationship between Epithelial-Mesenchymal Transition and Immune Checkpoints in Pancreatic Cancer.
In the second project, we will reveal the post-effects of Sars-Cov-2 Infection on several mediators of Epithelial-Mesenchymal Transition.
07.19.2022
Our TUBITAK 1001 Project Proposal was accepted to be funded! In this project, we will discover the roles of Gasdermins in Ovarian Cancer.
07.19. 2022
Our collaborative TUBITAK 1001 Project Proposal was accepted to be funded! In this project, we will collaborate with Cumhuriyet University to develop and characterize drug candidates for gastric cancer.
Tokat Gaziosmanpasa University
Department of Molecular Biology and Genetics
Cancer Research Laboratory
Tasliciftlik, 60250, Tokat, Turkey
Phone: +903562521616-3033
E-mail: ercan.cacan@gop.edu.tr
